# INVO BioScience Inc. (INVO)

Source: https://www.quantisnow.com/company/INVO
Generated: 2026-11-16T14:30:01.168Z

- Ticker: INVO
- Exchange: NASDAQ
- Sector: Health Care
- Industry: Medical/Dental Instruments
- Website: invobioscience.com

## About

INVO Bioscience, Inc., a medical device company, provides assisted reproductive technology solutions worldwide. It offers INVOcell, a patented intravaginal culture system used for the natural in vivo incubation of eggs and sperm during fertilization and early embryo development. The company was founded in 2007 and is based in Sarasota, Massachusetts.

## Latest INVO news and filings

- 2024-10-24 13:00 UTC [NAYA Biosciences Announces Initiation of Phase 1/2a Clinical Trial for its GPC3-targeted NK Engager Bispecific Antibody in Patients with Hepatocellular Carcinoma](https://www.quantisnow.com/insight/naya-biosciences-announces-initiation-of-phase-12a-clinical-trial-for-5736533)
- 2024-10-22 16:05 UTC [SEC Form RW filed by INVO BioScience Inc.](https://www.quantisnow.com/insight/sec-form-rw-filed-by-invo-bioscience-inc-5733070)
- 2024-10-21 13:00 UTC [INVO Bioscience Confirms Corporate Name Change and New Trading Symbol in Connection with Its Recent Merger with NAYA Biosciences](https://www.quantisnow.com/insight/invo-bioscience-confirms-corporate-name-change-and-new-trading-symbol-5731325)
- 2024-10-15 13:17 UTC [SEC Form 8-K] [INVO BioScience Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Completion of Acquisition or Disposition of Assets, Unregistered Sales of Equity Securities, Leadership Update, Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/invo-bioscience-inc-filed-sec-form-8-k-entry-into-a-5725114)
- 2024-10-14 13:18 UTC [INVO Bioscience and NAYA Biosciences Close Merger, Combined Company to Operate as NAYA Biosciences (NASDAQ: NAYA)](https://www.quantisnow.com/insight/invo-bioscience-and-naya-biosciences-close-merger-combined-company-to-5724167)
- 2024-10-01 21:26 UTC [SEC Form 8-K] [INVO BioScience Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits](https://www.quantisnow.com/insight/invo-bioscience-inc-filed-sec-form-8-k-entry-into-a-5711069)
- 2024-09-20 20:05 UTC [SEC Form 8-K] [INVO BioScience Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review, Financial Statements and Exhibits](https://www.quantisnow.com/insight/invo-bioscience-inc-filed-sec-form-8-k-notice-of-delisting-5700766)
- 2024-09-18 21:21 UTC [SEC Form 8-K] [INVO BioScience Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits](https://www.quantisnow.com/insight/invo-bioscience-inc-filed-sec-form-8-k-entry-into-a-5698565)
- 2024-08-14 20:06 UTC [SEC Form 8-K] [INVO BioScience Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits](https://www.quantisnow.com/insight/invo-bioscience-inc-filed-sec-form-8-k-results-of-operations-5659073)
- 2024-08-14 13:00 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by INVO BioScience Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-invo-bioscience-inc-5658474)
- 2024-08-14 13:00 UTC [INVO Reports Record Second Quarter 2024 Financial Results with 481% Revenue Growth and a $1.1 Million Improvement to Adjusted EBITDA](https://www.quantisnow.com/insight/invo-reports-record-second-quarter-2024-financial-results-with-481-5658442)
- 2024-07-05 20:05 UTC [SEC Form 8-K] [INVO BioScience Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits](https://www.quantisnow.com/insight/invo-bioscience-inc-filed-sec-form-8-k-entry-into-a-5595502)
- 2024-06-20 20:23 UTC [Market Chatter] [Invo Bioscience Says On June 18, 2024, Co Received Notice From Nasdaq Informing Co Was Granted Request For Continued Listing On Nasdaq](https://www.quantisnow.com/insight/invo-bioscience-says-on-june-18-2024-co-received-notice-5568841)
- 2024-06-20 20:19 UTC [SEC Form 8-K] [INVO BioScience Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/invo-bioscience-inc-filed-sec-form-8-k-notice-of-delisting-5568794)
- 2024-05-21 20:39 UTC [SEC Form S-3] [SEC Form S-3 filed by INVO BioScience Inc.](https://www.quantisnow.com/insight/sec-form-s-3-filed-by-invo-bioscience-inc-5507865)
- 2024-05-16 11:56 UTC [Market Chatter] [INNO BioScience shares are trading higher after the company reported a year-over-year increase in Q1 EPS results.](https://www.quantisnow.com/insight/inno-bioscience-shares-are-trading-higher-after-the-company-reported-5495508)
- 2024-05-15 20:51 UTC [SEC Form 8-K] [INVO BioScience Inc. filed SEC Form 8-K: Results of Operations and Financial Condition](https://www.quantisnow.com/insight/invo-bioscience-inc-filed-sec-form-8-k-results-of-operations-5494224)
- 2024-05-15 20:45 UTC [Market Chatter] [INVO Bioscience Q1 EPS $(0.42), Sales $1.58M Up From $348.02K YoY](https://www.quantisnow.com/insight/invo-bioscience-q1-eps-042-sales-158m-up-from-34802k-5494130)
- 2024-05-15 20:32 UTC [Market Insight] [12 Health Care Stocks Moving In Wednesday's After-Market Session](https://www.quantisnow.com/insight/12-health-care-stocks-moving-in-wednesdays-after-market-session-5493822)
- 2024-05-15 20:15 UTC [Market Insight] [Peering Into INVO Bioscience's Recent Short Interest](https://www.quantisnow.com/insight/peering-into-invo-biosciences-recent-short-interest-5493428)
- 2024-05-15 20:15 UTC [INVO Reports Record First Quarter 2024 Financial Results](https://www.quantisnow.com/insight/invo-reports-record-first-quarter-2024-financial-results-5493382)
- 2024-05-15 20:00 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by INVO BioScience Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-invo-bioscience-inc-5493023)
- 2024-05-14 17:30 UTC [Market Insight] [Why Alibaba Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session](https://www.quantisnow.com/insight/why-alibaba-shares-are-trading-lower-by-around-7-here-5488533)
- 2024-05-14 12:30 UTC [Market Insight] [Why Alcon Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket](https://www.quantisnow.com/insight/why-alcon-shares-are-trading-higher-by-over-10-here-5487604)
- 2024-05-06 21:30 UTC [SEC Form 8-K] [INVO BioScience Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits](https://www.quantisnow.com/insight/invo-bioscience-inc-filed-sec-form-8-k-entry-into-a-5463642)
- 2024-04-29 20:43 UTC [SEC Form 10-K] [SEC Form 10-K/A filed by INVO BioScience Inc. (Amendment)](https://www.quantisnow.com/insight/sec-form-10-ka-filed-by-invo-bioscience-inc-amendment-5441822)
- 2024-04-25 16:31 UTC [Market Insight] [12 Health Care Stocks Moving In Thursday's Intraday Session](https://www.quantisnow.com/insight/12-health-care-stocks-moving-in-thursdays-intraday-session-5432933)
- 2024-04-19 21:18 UTC [SEC Form 8-K] [INVO BioScience Inc. filed SEC Form 8-K: Termination of a Material Definitive Agreement, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits](https://www.quantisnow.com/insight/invo-bioscience-inc-filed-sec-form-8-k-termination-of-a-5421743)
- 2024-04-19 12:08 UTC [Market Insight] [12 Health Care Stocks Moving In Friday's Pre-Market Session](https://www.quantisnow.com/insight/12-health-care-stocks-moving-in-fridays-pre-market-session-5420105)
- 2024-04-18 16:31 UTC [Market Insight] [12 Health Care Stocks Moving In Thursday's Intraday Session](https://www.quantisnow.com/insight/12-health-care-stocks-moving-in-thursdays-intraday-session-5418386)
- 2024-04-18 15:32 UTC [Market Insight] [Why Las Vegas Sands Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session](https://www.quantisnow.com/insight/why-las-vegas-sands-shares-are-trading-lower-by-around-5418230)
- 2024-04-17 21:02 UTC [SEC Form 10-K] [SEC Form 10-K/A filed by INVO BioScience Inc. (Amendment)](https://www.quantisnow.com/insight/sec-form-10-ka-filed-by-invo-bioscience-inc-amendment-5416516)
- 2024-04-17 20:31 UTC [Market Insight] [12 Health Care Stocks Moving In Wednesday's After-Market Session](https://www.quantisnow.com/insight/12-health-care-stocks-moving-in-wednesdays-after-market-session-5416269)
- 2024-04-17 19:15 UTC [SEC Form 8-K] [INVO BioScience Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/invo-bioscience-inc-filed-sec-form-8-k-entry-into-a-5415704)
- 2024-04-17 18:34 UTC [Market Insight] [Crude Oil Dips 3%; U.S. Bancorp Profit Tops Views](https://www.quantisnow.com/insight/crude-oil-dips-3-us-bancorp-profit-tops-views-5415643)
- 2024-04-17 17:36 UTC [Market Insight] [Why Travelers Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session](https://www.quantisnow.com/insight/why-travelers-shares-are-trading-lower-by-around-8-here-5415574)
- 2024-04-17 16:44 UTC [Market Insight] [Nasdaq Down Over 1%; Sage Therapeutics Shares Plunge](https://www.quantisnow.com/insight/nasdaq-down-over-1-sage-therapeutics-shares-plunge-5415467)
- 2024-04-17 16:31 UTC [Market Insight] [12 Health Care Stocks Moving In Wednesday's Intraday Session](https://www.quantisnow.com/insight/12-health-care-stocks-moving-in-wednesdays-intraday-session-5415449)
- 2024-04-17 15:59 UTC [Market Insight] [Why Invo BioScience Stock Is Soaring Today](https://www.quantisnow.com/insight/why-invo-bioscience-stock-is-soaring-today-5415376)
- 2024-04-17 14:07 UTC [Market Insight] [Dow Surges 200 Points; Abbott Laboratories Posts Upbeat Earnings](https://www.quantisnow.com/insight/dow-surges-200-points-abbott-laboratories-posts-upbeat-earnings-5415152)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/INVO
- Earnings history: https://www.quantisnow.com/earnings/INVO
- Dividend history: https://www.quantisnow.com/dividends/INVO
- Insider transactions: https://www.quantisnow.com/insiders/INVO
- Options chain: https://www.quantisnow.com/options/INVO
- SEC 8-K filings only: https://www.quantisnow.com/company/INVO/8-k
- RSS and alerts for INVO: https://www.quantisnow.com/docs/rss-feeds.md
